AstraZeneca Begins Worldwide Withdrawal of COVID-19 Vaccine

AstraZeneca has commenced a global withdrawal of its COVID-19 vaccine on Tuesday, citing a “surplus” of updated jabs for new variants, months after acknowledging its rare risk of serious side effects. The pharmaceutical giant’s jab, Vaxzevria, is no longer authorized in the European Union as of May 7, after AstraZeneca requested the withdrawal of its “marketing authorization” on March 5, documents first reported by The Telegraph show. The removal of its authorization comes just weeks after the company admitted in a UK court document that its shot “can, in very rare cases, cause” blood clots and low platelets, a rare but serious condition known as thrombosis with thrombocytopenia syndrome (TSS). The company had originally denied a causal link....